Health and Medical Guide to Transplantation and Donation Bone Marrow Transplantation Health information topics about Bone Marrow Transplantation: Clinical Trials 1. ClinicalTrials.gov: Bone Marrow Transplantation National Institutes of Health http://clinicaltrials.gov/search/intervention=bone+marrow+transplantation&r... 2. Clinical Trials National Marrow Donor Program http://www.marrow.org/PATIENT/clinical_trials_idx.html Dictionaries/Glossaries 1. Definitions of Bone Marrow Transplantation Terms Health Resources and Services Administration http://www.hrsa.gov/osp/dot/glossary.htm 2. National Marrow Donor Program: Glossary National Marrow Donor Program http://www.marrow.org/GLOSSARY/glossary_idx.html Directories 1. U.S. NMDP Transplant Center Map National Marrow Donor Program http://www.marrow.org/cgi-bin/NETWORK/map.pl?ctr_typ=TC 2. Transplant Center Search Form BMT InfoNet http://www.bmtinfonet.org/centers/ 3. Patient Organizations National Marrow Donor Program http://www.marrow.org/cgi-bin/RELATED_ORG/search_orgs.pl?type=patient Financial Issues 1. Stem Cell Transplant Coverage Information National Marrow Donor Program http://www.marrow.org/PATIENT/transplant_coverage.html 2. Mapping the Maze: A Patient Financial Guide National Marrow Donor Program http://www.marrow.org/PATIENT/maze_financial_guide.html National Institutes of Health 1. Bone Marrow Transplantation and Peripheral Blood S National Cancer Institute http://cis.nci.nih.gov/fact/7_41.htm Newsletters/Print Publications 1. Blood & Marrow Transplant Newsletter BMT InfoNet http://www.bmtinfonet.org/letter.html Organizations 1. National Organ and Tissue Donation Initiative Dept. of Health and Human Services, Health Resources and Services Administration http://www.organdonor.gov 2. National Marrow Donor Program http://www.marrow.org/ 3. National Cancer Institute http://www.cancer.gov/ 4. Leukemia & Lymphoma Society http://www.leukemia-lymphoma.org/hm_lls Other Languages 1. Information and Resources in Chinese National Marrow Donor Program http://www.marrow.org/CHINESE/chinese_idx.html Overviews 1. Understanding Blood Stem Cell Transplants National Marrow Donor Program http://www.marrow.org/PATIENT/understanding_blood_stem_cell_transplants.htm... 2. Patient FAQs about Marrow and Blood Stem Cell Tran National Marrow Donor Program http://www.marrow.org/PATIENT/patient_faqs.html 3. Blood and Marrow Stem Cell Transplantation Leukemia & Lymphoma Society http://www.leukemia-lymphoma.org/all_mat_toc.adp?item_id=2443 Related Issues 1. Asian & Pacific Islander Donors Can Save L National Marrow Donor Program http://www.marrow.org/NMDP/api_english.html 2. Bone Marrow Donor Health History Guidelines Health Resources and Services Administration http://www.hrsa.gov/osp/dot/chart.htm 3. New Biotechnology Drug Approved to Treat Mucositis Food and Drug Administration http://www.fda.gov/bbs/topics/ANSWERS/2004/ANS01332.html 4. Non-Myeloablative Transplants (Mini-Transplants) National Marrow Donor Program http://www.marrow.org/PATIENT/mini_transplants.html 5. Problems in the Post-Transplant Period American Cancer Society http://www.cancer.org/docroot/ETO/content/ETO_1_4X_What_Does_The_Donor_Expe... 6. Steps of Marrow and PBSC (Peripheral Blood Stem Ce National Marrow Donor Program http://www.marrow.org/DONOR/steps_of_donation.html 7. How to Be a Bone Marrow or Blood Stem Cell Donor Mayo Foundation for Medical Education and Research http://www.mayoclinic.com/invoke.cfm?id=CA00047 8. Disease Information National Marrow Donor Program http://www.marrow.org/PATIENT/disease_info.html 9. Delayed Complications after a Blood Stem Cell Tran National Marrow Donor Program http://www.marrow.org/PATIENT/delayed_complications.html 10. Considerations for Choosing a Bone Marrow Transpla Health Resources and Services Administration http://www.hrsa.gov/osp/dot/choosebmt.htm 11. Changing Transplant Centers National Marrow Donor Program http://www.marrow.org/PATIENT/changing_transplant_centers.html Research 1. Advances in Stem Cell Transplants: A Primer for Pa National Marrow Donor Program http://www.marrow.org/PATIENT/advances_stem_cell_transplants_primer_patient... 2. New Drug for Mouth Sores after Bone Marrow Transpl American Cancer Society http://www.cancer.org/docroot/NWS/content/NWS_1_1x_New_Drug_for_Mouth_Sores... Seniors 1. Bone Marrow Transplants in Older Adults Mayo Foundation for Medical Education and Research http://www.mayoclinic.com/invoke.cfm?id=AN00883 Statistics 1. Facts and Figures National Marrow Donor Program http://www.marrow.org/MEDIA/facts_figures.pdf 2. How to Understand NMDP Transplant Center Statistic National Marrow Donor Program http://www.marrow.org/PATIENT/understanding_survival_statistics.html   Transplants / Organ Donations News From Medical News Today Latest Health News and Medical News posted throughout the day, every day. HeartWare Receives Second Patient Allotment Under Continued Access Protocol F... HeartWare International, Inc. (Nasdaq: HTWR; ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that the U.S... New Warning Signs May Predict Kidney Transplant Failure Kidney transplants that show a combination of fibrosis (scarring) and inflammation after one year are at higher risk of long-term transplant failure, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN)... New Research Demonstrates Safety Of Cord-blood-derived Stem Cell Treatments In a new peer-reviewed article published by the Journal of Translational Medicine, scientists from Beike Biotechnology, China's leading stem cell research and regenerative medicine company, and Medistem, Inc... Occurrence Of Increased Kidney Transplant Listings In Patients With Prior Non... Individuals who received a non-kidney organ transplant in the past may be more likely to be listed for a kidney transplant prior to initiation of dialysis (pre-emptive listing) than other candidates, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN)... Beaumont Hospitals Launches New Liver Transplant Program Beaumont Hospital, Royal Oak became Michigan's third liver transplant center on Aug. 31. A 59-year-old man from Royal Oak was the first patient to receive a liver transplant through Beaumont's new multi-organ transplant program. Under the leadership of Alan J. Koffron, M.D... Vitrolife: New Study Shows Improved Survival With Perfadex A recently published study in The Journal of Heart and Lung Transplantation shows that the patients who are most seriously ill before lung tranplantation have better one-year survival when Perfadex is used as the preservation solution for donor lungs compared with UW solution... Eyegenix™ Artificial Cornea Achieves Major Advancement Towards Curing Corne... Eyegenix™, the ophthalmic division of Cellular Bioengineering, Inc. (CBI), announced that the results of a pilot clinical trial using a synthetic cornea for which Eyegenix™ holds the exclusive global license for transplantation were published in the peer-reviewed journal, Science Translational Medicine (Volume 2, Issue 46, August, 25, 2010)... Launch Of New Cell Transplantation Journal A new and unique journal on cell transplantation aimed at helping translate laboratory findings into clinical applications is being launched by Cognizant Communication Corporation as a companion journal to Cell Transplantation. Cell Medicine, an online-only, open access journal, publishes research papers that promise to have direct clinical relevance. The journal is freely accessible here... Bone Marrow From An Aboriginal Canadian May Be Best Match For Baby With Rare ... Bone marrow from a matched Aboriginal Canadian donor may be the best chance Harold and Lindsey Bost's daughter, Leona, has for survival. The five-month-old was born with Cartilage-Hair Hypoplasia (CHH). CHH is a rare genetic disorder characterised by short stature, fine, sparse hair, and immunodeficiency requiring bone marrow or stem cell transplantation... Biosynthetic Corneas Restore Sight In Patients With Significant Vision Loss Patients with corneal damage and considerable vision loss had biosynthetic corneas implanted into their eyes with FibroGen's proprietary rhCIII (recombinant human type III collagen), which restored their vision and promoted nerve regeneration. A report on this 2-year Phase I clinical trial has been published in the peer-reviewed journal Science Translational Medicine... 3SBio And Isotechnika Pharma Announce Strategic Partnership To Develop And Co... 3SBio Inc. ("3SBio") (Nasdaq: SSRX), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products and Isotechnika Pharma Inc... Heart Transplant Patients With Common Disorder Have High Survival Rates Transplant surgery to correct the most common type of genetic heart disease yields similar short-term and potentially greater long-term survival rates as transplant surgery for other heart diseases, according to research reported in Circulation: Heart Failure, an American Heart Association journal... EHSI: New Stem-Cell Study An 'Encouraging Step' Towards Organ Regeneration Cindy Morrissey, President and CEO of Emerging Healthcare Solutions, Inc., called the results of a recent study on Friday an 'encouraging step' towards the use of stem cells to regenerate human organs. The research, published in the journal Nature, shows that it is possible to convert one stem cell type to another, without the need for genetic modification... Extensive Trial Confirms Benefits Of Early Steroid Withdrawal For Transplant ... A University of Cincinnati (UC) analysis of 10 years of data from local kidney transplant patients shows that patients removed from a corticosteroid regimen shortly after surgery have better graft survival rates, better survival rates and fewer cardiovascular events than patients kept on the traditional regimen of long-term steroids... Soligenix Announces Award Of $1.2 Million FDA Orphan Products Development Grant Soligenix, Inc. (OTC Bulletin Board: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company, announced that it has been awarded a three year $1.2 million clinical research grant by the Office of Orphan Products Development (OOPD) of the U.S. Food and Drug Administration (FDA) pursuant to its Orphan Products Development (OPD) Program...     HealthBusinessBuilder.com Build your Health Business Fast!